Inhibiting NF-κB activation by small molecules as a therapeutic strategy

NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses

Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182 · see citing works

Signaling to NF-κB

Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842 · see citing works

Activators and target genes of Rel/NF-κB transcription factors

Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · see citing works

Missing Pieces in the NF-κB Puzzle

Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1× · see citing works

Activators and Target Genes of Rel/NF-кB Transcription Factors

Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179 · see citing works

NF-κB: linking inflammation and immunity to cancer development and progression

Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,091 · see citing works

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754 · see citing works

Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · see citing works

Suppression of TNF-α-Induced Apoptosis by NF-κB

Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581 · see citing works

TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,581 · see citing works

NF-κB in cancer: from innocent bystander to major culprit

Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476 · see citing works

A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125 · see citing works

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M. S., Mann, M., Manning, A. M., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,042 · see citing works

Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of <i>Ikkβ</i>

Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884 · see citing works

The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation

Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,814 · see citing works

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769 · see citing works

Inhibition of NF-κB by Sodium Salicylate and Aspirin

Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,765 · see citing works

Chk1 is an essential kinase that is regulated by Atr and required for the G ₂ /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes &amp; Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · see citing works

The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,596 · see citing works

NF-κB activation by reactive oxygen species: Fifteen years later

Gloire, G., Legrand-Poels, S., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,540 · see citing works

Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation

Viatour, P., Merville, M., Bours, V., & Chariot, A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,497 · see citing works

The IKK NF-κB system: a treasure trove for drug development

Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364 · see citing works

Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway

Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G. M., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,361 · see citing works

Nuclear factor-κB: The enemy within

Aggarwal, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,289 · see citing works

Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

Chen, L., Fischle, W., Verdin, E. M., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,231 · see citing works

Shaping the nuclear action of NF-κB

Chen, L., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,219 · see citing works

IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK

Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., & Goeddel, D. V. (1997) · Science · doi:10.1126/science.278.5339.866 · Cited by 1,183 · see citing works

Identification and Characterization of an IκB Kinase

Régnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., & Rothe, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80344-x · Cited by 1,176 · see citing works

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.

Natarajan, K., Singh, S., Burke, T. R., Grünberger, D., & Aggarwal, B. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9090 · Cited by 1,140 · see citing works

Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

Wang, C.-Y., Cusack, J., Liu, R., & Baldwin, A. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 1,088 · see citing works

The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling

Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 957 · see citing works

Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.

Staal, F. J. T., Roederer, M., Herzenberg, L. A., & Herzenberg, L. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9943 · Cited by 956 · see citing works

How NF-κB is activated: the role of the IκB kinase (IKK) complex

Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 935 · see citing works

The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways

Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z., Karin, M., Ware, C. F., & Green, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00423-5 · Cited by 923 · see citing works

Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence

Lin, Y.-Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14255 · Cited by 919 · see citing works

IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy

Luo, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 879 · see citing works

The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism

Zhong, H., Suyang, H., Erdjument‐Bromage, H., Tempst, P., & Ghosh, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80222-6 · Cited by 828 · see citing works

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB

Chen, L., Mu, Y., & Greene, W. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf660 · Cited by 827 · see citing works

Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38

Madrid, L. V., Mayo, M. W., Reuther, J. Y., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101103200 · Cited by 777 · see citing works

Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1)

Vermeulen, L., Wilde, G. D., Damme, P. V., Berghe, W. V., & Haegeman, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760 · see citing works

Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation

Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 751 · see citing works

Role of NF-κB in p53-mediated programmed cell death

Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 735 · see citing works

Recognition and Signaling by Toll-Like Receptors

West, A. P., Koblansky, A. A., & Ghosh, S. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.115827 · Cited by 718 · see citing works

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708 · see citing works

p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor

Berghe, W. V., Plaisance, S., Boone, E., Bosscher, K. D., Schmitz, M. L., Fiers, W., & Haegeman, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3285 · Cited by 679 · see citing works

Selective Inhibition of NF-κB Activation by a Peptide That Blocks the Interaction of NEMO with the IκB Kinase Complex

May, M. J., D’Acquisto, F., Madge, L. A., Glöckner, J., Pober, J. S., & Ghosh, S. (2000) · Science · doi:10.1126/science.289.5484.1550 · Cited by 678 · see citing works

Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway

Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674 · see citing works

Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller‐Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 660 · see citing works

IκB kinase complexes: gateways to NF-κB activation and transcription

Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 652 · see citing works

Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit

Sizemore, N., Leung, S., & Stark, G. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4798 · Cited by 650 · see citing works

Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes

Shembade, N., Ma, A. I., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 644 · see citing works

Transcriptional Cross Talk between NF-κB and p53

Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598 · see citing works

In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-894 · Cited by 584 · see citing works

Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF.

Schulze‐Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., & Fiers, W. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05978.x · Cited by 577 · see citing works

Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1

Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 563 · see citing works

BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice

Burke, J. R., Pattoli, M. A., Gregor, K. R., Brassil, P. J., MacMaster, J. F., McIntyre, K. W., Yang, X., Iotzova, V. S., Clarke, W., Strnad, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209677200 · Cited by 550 · see citing works

Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

Kiernan, R. E., Brès, V., Ng, R. W. M., Coudart, M.-P., Messaoudi, S. E., Sardet, C., Jin, D., Emiliani, S., & Benkirane, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209572200 · Cited by 536 · see citing works

NF-κB, chemokine gene transcription and tumour growth

Richmond, A. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri887 · Cited by 523 · see citing works

The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase

Kwok, B. H. B., Koh, B. D., Ndubuisi, M. I., Elofsson, M., & Crews, C. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00049-7 · Cited by 516 · see citing works

Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli

Wu, Z., Shi, Y., Tibbetts, R. S., & Miyamoto, S. (2006) · Science · doi:10.1126/science.1121513 · Cited by 515 · see citing works

Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65

Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212389200 · Cited by 495 · see citing works

At the Crossroads of Inflammation and Cancer

Clevers, H. C. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 494 · see citing works

Sulindac Inhibits Activation of the NF-κB Pathway

Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 493 · see citing works

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N. T., Bancroft, C. C., Sausville, E. A., Adams, J., Elliott, P. J., & Waes, C. V. (2001) · PubMed · Cited by 473 · see citing works

Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II

Wang, D., Westerheide, S. D., Ostrander, J. H., & Baldwin, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001358200 · Cited by 454 · see citing works

Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms

Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 429 · see citing works

Lymphoid Malignancies: the dark side of B-cell differentiation

Shaffer, A. L., Rosenwald, A., & Staudt, L. M. (2002) · Nature reviews. Immunology · doi:10.1038/nri953 · Cited by 420 · see citing works

Nuclear Factor-κB Activation: From Bench to Bedside

Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417 · see citing works

Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones

García‐Piñeres, A., Castro, V., MORA, G. A., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 408 · see citing works

Erratum: Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment

Wang, Z., Boudjelal, M., Kang, S., Voorhees, J. J., & Fisher, G. J. (1999) · Nature Medicine · doi:10.1038/10577 · Cited by 404 · see citing works

Inhibition of the Mitogen-Activated Protein Kinase Kinase Superfamily by a Yersinia Effector

Orth, K., Palmer, L. E., Bao, Z., Stewart, S., Rudolph, A. E., Bliska, J. B., & Dixon, J. E. (1999) · Science · doi:10.1126/science.285.5435.1920 · Cited by 402 · see citing works

Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

Bubici, C., Papa, S., Dean, K., & Franzoso, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209936 · Cited by 399 · see citing works

Distinct Roles of the IκB Kinase α and β Subunits in Liberating Nuclear Factor κB (NF-κB) from IκB and in Phosphorylating the p65 Subunit of NF-κB

Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., & Stark, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110572200 · Cited by 391 · see citing works

Transcription factor cross-talk: the estrogen receptor and NF-κB

Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388 · see citing works

Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular Mechanisms

Zhang, S., Won, Y.-K., Ong, C. N., & Shen, H. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011053765976 · Cited by 383 · see citing works

Evidence that reactive oxygen species do not mediate NF‐κB activation

Hayakawa, M., Miyashita, H., Sakamoto, I., Kitagawa, M., Tanaka, H., Yasuda, H., Karin, M., & Kikugawa, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg332 · Cited by 381 · see citing works

An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses

Arbibe, L., Kim, D. W., Batsché, É., Pédron, T., Mateescu, B., Muchardt, C., Parsot, C., & Sansonetti, P. J. (2006) · Nature Immunology · doi:10.1038/ni1423 · Cited by 376 · see citing works

Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase

Kapahi, P., Takahashi, T., Natoli, G., Adams, S., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359 · see citing works

The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development

Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 348 · see citing works

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

Frantz, B., Ec, N., Bren, G. D., Steffan, N. M., Paya, C. V., Kincaid, R. L., Tocci, M. J., O’Keefe, S. J., & O’Neill, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06329.x · Cited by 334 · see citing works

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

Pahl, H. L., Krauss, B., Schulze‐Osthoff, K., Decker, T., Traenckner, E. B.-M., Vogt, M., Myers, C., Parks, T., Warring, P., Mühlbacher, A., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1829 · Cited by 334 · see citing works

Antigen-Receptor Signaling to Nuclear Factor κB

Schulze‐Luehrmann, J., & Ghosh, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.010 · Cited by 330 · see citing works

PIDD Mediates NF-κB Activation in Response to DNA Damage

Janssens, S., Tinel, A., Lippens, S., & Tschopp, J. (2005) · Cell · doi:10.1016/j.cell.2005.09.036 · Cited by 319 · see citing works

CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

Kato, T., Delhase, M., Hoffmann, A., & Karin, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00358-7 · Cited by 313 · see citing works

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

Takada, Y., Bhardwaj, A., Potdar, P. D., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310 · see citing works

The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activity

Schesser, K., Spiik, A., Dukuzumuremyi, J., Neurath, M. F., Pettersson, S., & Wolf‐Watz, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00851.x · Cited by 280 · see citing works

Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

van Hogerlinden, M., Rozell, B., Ährlund‐Richter, L., & Toftgård, R. (1999) · PubMed · Cited by 277 · see citing works

Cutting Edge: Salmonella AvrA Effector Inhibits the Key Proinflammatory, Anti-Apoptotic NF-κB Pathway

Collier-Hyams, L. S., Zeng, H., Sun, J., Tomlinson, A. D., Bao, Z., Chen, H., Madara, J., Orth, K., & Neish, A. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2846 · Cited by 276 · see citing works

Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation

Qiu, D., Zhao, G., Aoki, Y., Shi, L., Uyei, A., Nazarian, S., Ng, J. C.-H., & Kao, P. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13443 · Cited by 269 · see citing works

Inflammation-associated cancer: NF-κB is the lynchpin

Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 268 · see citing works

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors

Gurova, K. V., Hill, J. E., Guo, C., Prokvolit, A., Burdelya, L. G., Samoylova, E. M., Khodyakova, A. V., Ganapathi, R. N., Ganapathi, M. K., Tararova, N. D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508888102 · Cited by 266 · see citing works

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB–regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis

Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., & Aggarwal, B. B. (2008) · Blood · doi:10.1182/blood-2007-10-117994 · Cited by 265 · see citing works

Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

Duffey, D. C., Chen, Z., Dong, G., Ondrey, F. G., Wolf, J. S., Brown, K., Siebenlist, U. K., & Waes, C. V. (1999) · PubMed · Cited by 263 · see citing works

p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1

Bohuslav, J., Chen, L., Kwon, H., Mu, Y., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313509200 · Cited by 256 · see citing works

The pro‐ or anti‐apoptotic function of NF‐κB is determined by the nature of the apoptotic stimulus

Kaltschmidt, B., Kaltschmidt, C., Hofmann, T. G., Hehner, S. P., Dröge, W., & Schmitz, M. L. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01421.x · Cited by 252 · see citing works

Inhibition of HIV-1 replication and NF-x B activity by cysteine and cysteine derivatives

Mihm, S., Ennen, J., Pessara, U., Kurth, R., & Dröge, W. (1991) · AIDS · doi:10.1097/00002030-199105000-00004 · Cited by 252 · see citing works

Cross-talk between nuclear receptors and nuclear factor κB

Bosscher, K. D., Berghe, W. V., & Haegeman, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209935 · Cited by 247 · see citing works

Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses

Hiscott, J. B., Nguyen, T.-L. A., Argüello, M., Nakhaei, P., & Paz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209941 · Cited by 246 · see citing works

Aggresome Disruption: A Novel Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic Cancer Cells

Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Andtbacka, R. H. I., Dunner, K., Pal, A., Bornmann, W. G., Chiao, P. J., Huang, P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2961 · Cited by 240 · see citing works

Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB

Huang, W., Ju, T.-K., Hung, M., & Chen, C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.019 · Cited by 239 · see citing works

Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase

Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., Mercurio, F., Manning, A. M., Ciechanover, A. J., & Ben‐Neriah, Y. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6486 · Cited by 239 · see citing works

Transient and Selective NF-κB p65 Serine 536 Phosphorylation Induced by T Cell Costimulation Is Mediated by IκB Kinase β and Controls the Kinetics of p65 Nuclear Import

Mattioli, I., Sebald, A., Bucher, C., Charles, R., Nakano, H., Doi, T., Kracht, M., & Schmitz, M. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6336 · Cited by 230 · see citing works

C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases

Li, J., & Fang, C. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.014 · Cited by 228 · see citing works

Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes

Schwabe, R. F., & Brenner, D. A. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2002 · Cited by 227 · see citing works

Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation

Zhou, H., Monack, D. M., Kayagaki, N., Wertz, I. E., Yin, J., Wolf, B. B., & Dixit, V. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051194 · Cited by 226 · see citing works

Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation

Rodríguez, M. S., Thompson, J., Hay, R. T., & Dargemont, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9108 · Cited by 224 · see citing works

Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells.

Jobin, C., Panja, A. B., Hellerbrand, C., Iimuro, Y., DiDonato, J. A., Brenner, D. A., & Sartor, R. B. (1998) · PubMed · Cited by 224 · see citing works

Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunit

Yang, X., Huang, B., Li, M., Lamb, A., Kelleher, N. L., & Chen, L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.55 · Cited by 217 · see citing works

TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105

Belich, M. P., Salmerón, A., Johnston, L. H., & Ley, S. C. (1999) · Nature · doi:10.1038/16946 · Cited by 213 · see citing works

Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb

Kanegae, Y., Tavares, A. T., Belmonte, J. C. I., & Verma, I. M. (1998) · Nature · doi:10.1038/33429 · Cited by 203 · see citing works

Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.

Torgerson, T. R., Colosia, A. D., Donahue, J. P., Lin, Y. Z., & Hawiger, J. (1998) · PubMed · Cited by 180 · see citing works

WIP1 phosphatase is a negative regulator of NF-κB signalling

Chew, J., Biswas, S. K., Shreeram, S., Humaidi, M., Wong, E. T., Dhillon, M. K., Teo, H., Hazra, A., Fang, C. C., López‐Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172 · see citing works

An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages

Powell, P. P., Dixon, L. K., & Parkhouse, R. M. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8527-8533.1996 · Cited by 171 · see citing works

The NF-κB Activation in Lymphotoxin β Receptor Signaling Depends on the Phosphorylation of p65 at Serine 536

Jiang, X., Takahashi, N., Matsui, N., Tetsuka, T., & Okamoto, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208696200 · Cited by 171 · see citing works

Inhibition of Proinflammatory Molecule Production by Adenovirus-Mediated Expression of a Nuclear Factor κB Super-Repressor in Human Intestinal Epithelial Cells

Jobin, C., Panja, A. B., Hellerbrand, C., Iimuro, Y., DiDonato, J. A., Brenner, D. A., & Sartor, R. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.410 · Cited by 171 · see citing works

Flavopiridol Inhibits NF-κB Activation Induced by Various Carcinogens and Inflammatory Agents through Inhibition of IκBα Kinase and p65 Phosphorylation

Takada, Y., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304546200 · Cited by 169 · see citing works

Gallic Acid Suppresses Lipopolysaccharide-Induced Nuclear Factor-κB Signaling by Preventing RelA Acetylation in A549 Lung Cancer Cells

Choi, K., Lee, Y., Jung, M. G., Kwon, S. H., Kim, M., Jun, W. J., Lee, J., Lee, J. M., & Yoon, H. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0239 · Cited by 167 · see citing works

Regulation of NF-κB, AP-1, NFAT, and STAT1 Nuclear Import in T Lymphocytes by Noninvasive Delivery of Peptide Carrying the Nuclear Localization Sequence of NF-κB p50

Torgerson, T. R., Colosia, A. D., Donahue, J. P., Lin, Y.-Z., & Hawiger, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6084 · Cited by 167 · see citing works

Identification of NAP1, a Regulatory Subunit of IκB Kinase-Related Kinases That Potentiates NF-κB Signaling

Fujita, F., Taniguchi, Y., Kato, T., Narita, Y., Furuya, A., Ogawa, T., Sakurai, H., Joh, T., Itoh, M., Delhase, M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7780-7793.2003 · Cited by 164 · see citing works

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.

Williams, S. A., Pettaway, C. A., Song, R., Papandreou, C. N., Logothetis, C. J., & McConkey, D. J. (2003) · PubMed · Cited by 164 · see citing works

Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability

Demarchi, F., Bertoli, C., Sandy, P., & Schneider, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305676200 · Cited by 162 · see citing works

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation

Meyer, S. M., Kohler, N. G., & Joly, A. H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00930-7 · Cited by 161 · see citing works

Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis

Bushdid, P. B., Brantley, D. M., Yull, F. E., Blaeuer, G. L., Hoffman, L. H., Niswander, L. A., & Kerr, L. D. (1998) · Nature · doi:10.1038/33435 · Cited by 158 · see citing works

Inhibitor κB-like proteins from a polydnavirus inhibit NF-κB activation and suppress the insect immune response

Thoetkiattikul, H., Beck, M. H., & Strand, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505240102 · Cited by 151 · see citing works

The Replacement of ATP by the Competitive Inhibitor Emodin Induces Conformational Modifications in the Catalytic Site of Protein Kinase CK2

Battistutta, R., Sarno, S., Moliner, E. D., Papinutto, E., Zanotti, G., & Pinna, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004257200 · Cited by 148 · see citing works

NF-κB in cancer—a friend turned foe

Ravi, R. K. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.003 · Cited by 147 · see citing works

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways

Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 146 · see citing works

Role of cysteine residues of p65/NF-κB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential

García‐Piñeres, A., Lindenmeyer, M. T., & Merfort, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.024 · Cited by 146 · see citing works

Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium

Broide, D. H., Lawrence, T., Doherty, T. A., Cho, J. Y., Miller, M., McElwain, K., McElwain, S., & Karin, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509235102 · Cited by 144 · see citing works

Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1

Manna, S. K., Kuo, M. T., & Aggarwal, B. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202811 · Cited by 144 · see citing works

Functional Interplay between Acetylation and Methylation of the RelA Subunit of NF-κB

Yang, X., Tajkhorshid, E., & Chen, L. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01343-09 · Cited by 143 · see citing works

The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activationPreprint

Hur, G. M., Lewis, J., Yang, Q., Lin, Y., Nakano, H., Nedospasov, S. A., & Liu, Z.-G. (2003) · Genes & Development · doi:10.1101/gad.1062403 · Cited by 140 · see citing works

Inhibition of Nuclear Factor κB Activation by a Virus-encoded IκB-like Protein

Revilla, Y., Callejo, M., Rodríguez, J. M., Culebras, E., Nogal, M. L., Salas, M. L., Viñuela, E., & Fresno, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5405 · Cited by 139 · see citing works

NF-κB: arresting a major culprit in cancer

Haefner, B. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02309-7 · Cited by 138 · see citing works

Protein phosphatase 2A interacts with and directly dephosphorylates RelA

Yang, J., Fan, G.-H., Wadzinski, B. E., Sakurai, H., & Richmond, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106103200 · Cited by 130 · see citing works

Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression

Aguilera, C. N., Hoya-Arias, R., Haegeman, G., Espinosa, L., & Bigas, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404429101 · Cited by 126 · see citing works

Aspirin Induces Apoptosis through the Inhibition of Proteasome Function

Dikshit, P., Chatterjee, M., Goswami, A., Mishra, A., & Jana, N. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602629200 · Cited by 126 · see citing works

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors

Zhu, H., Zhang, L., Dong, F., Guo, W., Wu, S., Teraishi, F., Davis, J. J., Chiao, P. J., & Fang, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208683 · Cited by 125 · see citing works

NF-κB in Human Disease: Current Inhibitors and Prospects for De Novo Structure Based Design of Inhibitors

Pande, V., & Ramos, M. J. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363180 · Cited by 125 · see citing works

Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-kB

Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10631 · Cited by 124 · see citing works

Flavopiridol Induces p53 via Initial Inhibition of Mdm2 and p21 and, Independently of p53, Sensitizes Apoptosis-Reluctant Cells to Tumor Necrosis Factor

Demidenko, Z. N., & Blagosklonny, M. V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0204 · Cited by 123 · see citing works

Nuclear Factor-κB Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer

Shishodia, S., & Aggarwal, B. B. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_8 · Cited by 123 · see citing works

Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB–regulated gene products

Ahn, K. S., Sethi, G., Chao, T., Neuteboom, S., Chaturvedi, M. M., Palladino, M. A., Younes, A., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-04-084996 · Cited by 122 · see citing works

Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB.

Mohan, R. R., Mohan, R. R., Kim, W. J., & Wilson, S. E. (2000) · PubMed · Cited by 119 · see citing works

Activation of p53 by roscovitine-mediated suppression of MDM2 expression

Lu, W., Chen, L., Peng, Y., & Chen, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204412 · Cited by 117 · see citing works

Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model

Kawamura, I., Morishita, R., Tomita, N., Lacey, E., Aketa, M., Tsujimoto, S., Manda, T., Tomoi, M., Kida, I., Higaki, J., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300819 · Cited by 117 · see citing works

Inhibition of NF-κB Activation by Panepoxydone

Erkel, G., Anke, T., & Sterner, O. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1335 · Cited by 113 · see citing works

Gene Expression Profiling of Lymphoid Malignancies

Staudt, L. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103941 · Cited by 112 · see citing works

Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection

Neznanov, N., Chumakov, K. M., Neznanova, L., Almasan, A., Banerjee, A. K., & Gudkov, A. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502303200 · Cited by 109 · see citing works

Epidermal growth factor (EGF) activates nuclear factor-κB through IκBα kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IκBα

Sethi, G., Ahn, K. S., Chaturvedi, M., & Aggarwal, B. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210544 · Cited by 105 · see citing works

Regulation of NF‐κB Action by Reversible Acetylation

Greene, W. C., & Chen, L. (2004) · Novartis Foundation symposium · doi:10.1002/0470862637.ch15 · Cited by 102 · see citing works

Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3.

Kolenko, V. M., Bloom, T., Rayman, P. A., Bukowski, R. M., Hsi, E. D., & Finke, J. H. (1999) · PubMed · Cited by 102 · see citing works

Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65

Shimada, H., & Rajagopalan, L. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099630 · Cited by 98 · see citing works

Nuclear factor‐KappaB modulation as a therapeutic approach in hematologic malignancies

Panwalkar, A. W., Verstovšek, S., & Giles, F. J. (2004) · Cancer · doi:10.1002/cncr.20182 · Cited by 97 · see citing works

Poxviral Regulation of the Host NF-κB Response: the Vaccinia Virus M2L Protein Inhibits Induction of NF-κB Activation via an ERK2 Pathway in Virus-Infected Human Embryonic Kidney Cells

Gedey, R., Jin, X.-L., Hinthong, O., & Shisler, J. L. (2006) · Journal of Virology · doi:10.1128/jvi.00935-06 · Cited by 97 · see citing works

NF‐κB is involved in the survival of cerebellar granule neurons: association of Iκβ phosphorylation with cell survival

Koulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00134.x · Cited by 97 · see citing works

Preadministration of High-Dose Salicylates, Suppressors of NF-κB Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy

McCarty, M. F., & Block, K. I. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406291499 · Cited by 95 · see citing works

Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor‐κB activation in J774 macrophages

D’Acquisto, F., Sautebin, L., Iuvone, T., Rosa, M. D., & Carnuccio, R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01407-0 · Cited by 94 · see citing works

Inhibition of tumor growth by NF‐κB inhibitors

Umezawa, K. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00285.x · Cited by 91 · see citing works

Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.

Palayoor, S. T., Bump, E. A., Calderwood, S. K., Bartol, S., & Coleman, C. N. (1998) · PubMed · Cited by 91 · see citing works

FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.

Venkataraman, L., Burakoff, S. J., & Sen, R. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1091 · Cited by 90 · see citing works

Signal-Induced Degradation of IκBα: Association with NF-κB and the PEST Sequence in IκBα Are Not Required

Antwerp, D. J. V., & Verma, I. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6037 · Cited by 90 · see citing works

A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-κB Activation by API2·MALT1 Fusions

Noels, H., Loo, G., Hagens, S., Broeckx, V., Beyaert, R., Marynen, P., & Baens, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611038200 · Cited by 88 · see citing works

Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs.

Bentires‐Alj, M., Hellin, A., Ameyar‐Zazoua, M., Chouaı̈b, S., Merville, M. P., & Bours, V. (1999) · PubMed · Cited by 88 · see citing works

Tumor Suppressor MMAC/PTEN Inhibits Cytokine-induced NFκB Activation without Interfering with the IκB Degradation Pathway

Koul, D., Yao, Y., Abbruzzese, J. L., Yung, W. K. A., & Reddy, S. A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007806200 · Cited by 87 · see citing works

Inhibition of NF-κB Activity in Human T Lymphocytes Induces Caspase-Dependent Apoptosis Without Detectable Activation of Caspase-1 and -3

Kolenko, V. M., Bloom, T., Rayman, P. A., Bukowski, R. M., Hsi, E. D., & Finke, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.590 · Cited by 87 · see citing works

TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis

Abu‐Amer, Y., Dowdy, S. F., Ross, F. P., Clohisy, J. C. F., & Teitelbaum, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104725200 · Cited by 85 · see citing works

Inhibition of transcription factor NF-κB signaling proteins IKKβ and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity

Liang, M., Bardhan, S., Pace, E. A., Rosman, D. S., Beutler, J. A., Porco, J. A. J., & Gilmore, T. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.013 · Cited by 83 · see citing works

Salicylates Inhibit NF-κB Activation and Enhance TNF-α-Induced Apoptosis in Human Pancreatic Cancer Cells

McDade, T. P., Perugini, R. A., Vittimberga, F. J., Carrigan, R. C., & Callery, M. P. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1998.5560 · Cited by 82 · see citing works

A Virulence Factor of Myxoma Virus Colocalizes with NF-κB in the Nucleus and Interferes with Inflammation

Camus-Bouclainville, C., Fiette, L., Bouchiha, S., Pignolet, B., Counor, D., Filipe, C., Gelfi, J., & Messud-Petit, F. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2510-2516.2004 · Cited by 82 · see citing works

A Small Molecule Ubiquitination Inhibitor Blocks NF-κB-dependent Cytokine Expression in Cells and Rats

Swinney, D. C., Xu, Y.-Z., Scarafia, L. E., Lee, I., Mak, A. Y., Gan, Q.-F., Ramesha, C. S., Mulkins, M. A., Dunn, J., So, O., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200842200 · Cited by 82 · see citing works

Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ

Nagashima, K., Sasseville, V. G., Wen, D., Bielecki, A., Yang, H., Simpson, C., Grant, E. P., Hepperle, M. E., Harriman, G., Jaffee, B., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3852 · Cited by 78 · see citing works

NF‐κB is involved in the survival of cerebellar granule neurons: association of IκBβ phosphorylation with cell survival

Koulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00303.x · Cited by 77 · see citing works

Activation of the Heat Shock Factor 1 by Serine Protease Inhibitors

Rossi, A., Elia, G., & Santoro, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16446 · Cited by 77 · see citing works

Cisplatin Mimics ARF Tumor Suppressor Regulation of RelA (p65) Nuclear Factor-κB Transactivation

Campbell, K. J., Witty, J., Rocha, S., & Perkins, N. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2234 · Cited by 77 · see citing works

Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation

Tepper, M. A., Nadler, S. G., Esselstyn, J. M., & STERBENZ, K. G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2427 · Cited by 74 · see citing works

R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy

Dey, A., Wong, E. T., Cheok, C. F., Tergaonkar, V., & Lane, D. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402257 · Cited by 73 · see citing works

Nuclear transport as a target for cell growth

Kau, T. R., & Silver, P. A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02562-x · Cited by 71 · see citing works

Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy

Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70 · see citing works

The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD

Bernard, D., Monté, D., Vandenbunder, B., & Abbadie, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205536 · Cited by 70 · see citing works

Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer

Allen, C. T., Saigal, K., Nottingham, L. K., Arun, P., Chen, Z., & Waes, C. V. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4470 · Cited by 70 · see citing works

Potent Inhibitors of Proteasome

Iqbal, M. A., Chatterjee, S., Kauer, J. C., Das, M. K., Messina, P. A., Freed, B., Biazzo, W., & Siman, R. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00013a002 · Cited by 68 · see citing works

Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway.

Wechsler, A. S., Gordon, M., Dendorfer, U., & LeClair, K. P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2515 · Cited by 67 · see citing works

Retroinfusion of NFκB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs

Kupatt, C., Wichels, R., Deiss, M., Molnar, A., Lebherz, C., Raake, P. W. J., von Degenfeld, G., Hahnel, D., & Boekstegers, P. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301673 · Cited by 67 · see citing works

NF-kB inhibitor blocks B cell development at two checkpoints

Feng, B., Cheng, S., Pear, W. S., & Liou, H. (2004) · Medical Immunology · doi:10.1186/1476-9433-3-1 · Cited by 66 · see citing works

Denbinobin inhibits nuclear factor-κB and induces apoptosis via reactive oxygen species generation in human leukemic cells

Sánchez‐Duffhues, G., Calzado, M. A., de Vinuesa, A. G., Appendino, G., Fiebich, B. L., Loock, U., Lefarth‐Risse, A., Krohn, K., & Muñóz, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.004 · Cited by 65 · see citing works

Caspase‐8 and caspase‐10 activate NF‐κB through RIP, NIK and IKKα kinases

Shikama, Y., Yamada, M., & Miyashita, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200324013 · Cited by 62 · see citing works

Expression and induction of nuclear factor-kappa B-related proteins in thymocytes.

Sen, J. M., Venkataraman, L., Shinkai, Y., Pierce, J. W., Alt, F. W., Burakoff, S. J., & Sen, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3213 · Cited by 61 · see citing works

Synergistic Effect of Histone Deacetylase Inhibitors FK228 and m-Carboxycinnamic Acid Bis-Hydroxamide with Proteasome Inhibitors PSI and PS-341 against Gastrointestinal Adenocarcinoma Cells

Adachi, M., Zhang, Y., Zhao, X., Minami, T., Kawamura, R., Hinoda, Y., & Imai, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0806 · Cited by 59 · see citing works

Protease inhibitors differentially regulate tumor necrosis factor- induced apoptosis, nuclear factor-kappa B activation, cytotoxicity, and differentiation

Higuchi, M., Singh, S., Chan, H., & Aggarwal, B. B. (1995) · Blood · doi:10.1182/blood.v86.6.2248.bloodjournal8662248 · Cited by 58 · see citing works

Inhibition of NF-κB Acetylation and its Transcriptional Activity by Daxx

Park, J., Lee, J. H., La, M., Jang, M. J., Chae, G. W., Kim, S. B., Tak, H., Jung, Y., Byun, B., Ahn, J. K., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.047 · Cited by 57 · see citing works

Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor

Barišić, S., Strozyk, E. A., Peters, N., Walczak, H., & Kulms, D. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.98 · Cited by 57 · see citing works

Naturally occurring and synthetic inhibitors of NF-kappaB functions.

Umezawa, K., Ariga, A., & Matsumoto, N. (2000) · PubMed · Cited by 56 · see citing works

The Non-ankyrin C Terminus of IκBα Physically Interacts with p53 in Vivo and Dissociates in Response to Apoptotic Stress, Hypoxia, DNA Damage, and Transforming Growth Factor-β1-mediated Growth Suppression

Chang, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106607200 · Cited by 54 · see citing works

Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation

Sreenivasan, Y., Sarkar, A., & Manna, S. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206486 · Cited by 53 · see citing works

Changes of NF-κB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species

Li, H.-L. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.431 · Cited by 52 · see citing works

Development of a Structural Model for NF-κB Inhibition of Sesquiterpene Lactones Using Self-Organizing Neural Networks

Wagner, S., Hofmann, A., Siedle, B., Terfloth, L., Merfort, I., & Gasteiger, J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051125n · Cited by 52 · see citing works

Targeting β-Transducin Repeat–Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells

Tang, W., Li, Y., Yu, D., Thomas‐Tikhonenko, A., Spiegelman, V. S., & Fuchs, S. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2597 · Cited by 52 · see citing works

NF‐κB and the link between inflammation and cancer

DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,490 · see citing works

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

Shih, R., Wang, C.-Y., & Yang, C. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00077 · Cited by 912 · see citing works

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9235-2 · Cited by 806 · see citing works

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease

Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 698 · see citing works

Mechanisms of NF-&amp;kappa;B p65 and strategies for therapeutic manipulation

Giridharan, S., & Srinivasan, M. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s140188 · Cited by 686 · see citing works

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

Park, M., & Hong, J. T. (2016) · Cells · doi:10.3390/cells5020015 · Cited by 631 · see citing works

Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 524 · see citing works

Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation

Rahimifard, M., Maqbool, F., Moeini-Nodeh, S., Niaz, K., Abdollahi, M., Braidy, N., Nabavi, S. M., & Nabavi, S. F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.02.004 · Cited by 481 · see citing works

Role of the NFκB-signaling pathway in cancer

Xia, L., Tan, S., Zhou, Y., Lin, J., Wang, H., Oyang, L., Tian, Y., Liu, L., Su, M., Wang, H., et al. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s161109 · Cited by 461 · see citing works

Epigenetic changes induced by curcumin and other natural compounds

Reuter, S., Gupta, S. C., Park, B., Goel, A., & Aggarwal, B. B. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0222-1 · Cited by 363 · see citing works

Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects

Hassan, F., Rehman, M. S.-U., Khan, M. S., Ali, M. A., Javed, A., Nawaz, A. S., & Yang, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00514 · Cited by 369 · see citing works

Curcumin mediates anticancer effects by modulating multiple cell signaling pathways

Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 334 · see citing works

Skin aging and oxidative stress: Equol’s anti-aging effects via biochemical and molecular mechanisms

Lephart, E. D. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.001 · Cited by 325 · see citing works

The Role of Curcumin in Cancer Treatment

Zoi, V., Galani, V., Lianos, G. D., Voulgaris, S., Kyritsis, A. P., & Alexiou, G. Α. (2021) · Biomedicines · doi:10.3390/biomedicines9091086 · Cited by 335 · see citing works

Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols

Gupta, S. C., Tyagi, A. K., Deshmukh-Taskar, P., Hinojosa, M., Prasad, S., & Aggarwal, B. B. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.006 · Cited by 317 · see citing works

Chemosensitization of tumors by resveratrol

Gupta, S. C., Kannappan, R., Reuter, S., Kim, J. H., & Aggarwal, B. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05852.x · Cited by 308 · see citing works

NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells

Pires, B. R. B., Mencalha, A. L., Ferreira, G. M., de Souza, W. F., Morgado-Díaz, J. A., Maia, A. M., Corrêa, S., & Abdelhay, E. S. F. W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169622 · Cited by 296 · see citing works

Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin

Rosales‐Corral, S., Acuña-Castroviejo, D., Coto‐Montes, A. M., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 293 · see citing works

Macrophages, Inflammation, and Lung Cancer

Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S. C., Lam, W. L., & Bennewith, K. L. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 285 · see citing works

Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium

Konkankit, C. C., Marker, S. C., Knopf, K. M., & Wilson, J. J. (2018) · Dalton Transactions · doi:10.1039/c8dt01858h · Cited by 285 · see citing works

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283 · see citing works

Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers

Soundararajan, P., & Kim, J. S. (2018) · Molecules · doi:10.3390/molecules23112983 · Cited by 268 · see citing works

Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA

Zou, Z., Huang, B., Wu, X., Zhang, H., Qi, J., Bradner, J. E., Nair, S. K., & Chen, L.-F. (2013) · Oncogene · doi:10.1038/onc.2013.179 · Cited by 260 · see citing works

Antiviral potential of curcumin

Mathew, D. C., & Hsu, W. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.017 · Cited by 260 · see citing works

Emerging roles of lncRNAs in the post-transcriptional regulation in cancer

He, R., Luo, D., & Mo, Y. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.01.003 · Cited by 258 · see citing works

The Science behind Microgreens as an Exciting New Food for the 21st Century

Choe, U., Yu, L. L., & Wang, T. T. Y. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03096 · Cited by 277 · see citing works

TF-PROTACs Enable Targeted Degradation of Transcription Factors

Liu, J., Chen, H., Kaniskan, H. Ü., Xie, L., Chen, X., Jin, J., & Wei, W. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03852 · Cited by 247 · see citing works

Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases

Gupta, S. C., Kunnumakkara, A. B., Aggarwal, S., & Aggarwal, B. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02160 · Cited by 246 · see citing works

NF-kappaB: Two Sides of the Same Coin

Pires, B. R. B., Silva, R. C. M. C., Ferreira, G. M., & Abdelhay, E. S. F. W. (2018) · Genes · doi:10.3390/genes9010024 · Cited by 235 · see citing works

NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases

Fiordelisi, A., Iaccarino, G., Morisco, C., Coscioni, E., & Sorriento, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071599 · Cited by 217 · see citing works

NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols

Singh, S. S., Nand, S., Birla, H., Zahra, W., Singh, S. P., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00147-2 · Cited by 215 · see citing works

Valorization of pomelo ( Citrus grandis Osbeck) peel: A review of current utilization, phytochemistry, bioactivities, and mechanisms of action

Tocmo, R., Peña-Fronteras, J. T., Calumba, K. F., Mendoza, M., & Johnson, J. J. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12561 · Cited by 221 · see citing works

Small Molecule NF-κB Pathway Inhibitors in Clinic

Ramadass, V., Vaiyapuri, T., & Tergaonkar, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145164 · Cited by 214 · see citing works

Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264.7 macrophages

Moro, C., Palacios, I., Lozano, M., D’Arrigo, M., Guillamón, E., Villares, A., Martínez, J. A., & Garcia-Lafuente, A. M. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.07.049 · Cited by 208 · see citing works

Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB

D’Ignazio, L., Batie, M., & Rocha, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020021 · Cited by 206 · see citing works

Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality

Choi, H., Kim, Y., Mirzaaghasi, A., Heo, J., Kim, Y. N., Shin, J. H., Kim, S., Kim, N. H., Cho, E. S., Yook, J. I., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6980 · Cited by 203 · see citing works

Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms

Fan, W., Huang, Y., Zheng, H., Li, S., Li, Z., Li, Y., Cheng, X., He, C., & Sun, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110915 · Cited by 205 · see citing works

Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression

Puar, Y., Shanmugam, M. K., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 199 · see citing works

Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway

Lu, C., Yuan, Z., Zhang, X., Yan, R., Zhao, Y., Liao, M., & Chen, J. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.06.010 · Cited by 194 · see citing works

Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions

Maccari, R., & Ottanà, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500907a · Cited by 194 · see citing works

TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: Crosstalk between NF-κB and PPAR-γ

Zhang, Y., Yang, X., Bian, F., Wu, P., Xing, S., Xu, G., Li, W., Chi, J., Ouyang, C., Zheng, T., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.012 · Cited by 193 · see citing works

Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines

Yasui, Y., Hosokawa, M., Mikami, N., Miyashita, K., & Tanaka, T. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.05.006 · Cited by 191 · see citing works

Role of inflammatory signaling in atrial fibrillation

Scott, L., Li, N., & Dobrev, D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.020 · Cited by 188 · see citing works

Interplay between DNA repair and inflammation, and the link to cancer

Kidane, D., Chae, W. J., Czochor, J. R., Eckert, K. A., Glazer, P. M., Bothwell, A. L. M., & Sweasy, J. B. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.875514 · Cited by 186 · see citing works

METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-κB Signaling Pathway

Wang, J., Yan, S., Lu, H., Wang, S., & Xu, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/3120391 · Cited by 186 · see citing works

TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K/AKT pathway after spinal cord injury

Xu, S., Wang, J. Q., Jiang, J., Song, J., Zhu, W. P., Zhang, F., Shao, M., Xu, H., Ma, X., & Lyu, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02824-z · Cited by 171 · see citing works

NF-κB in Cancer: A Matter of Life and Death

Aggarwal, B. B., & Sung, B. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0260 · Cited by 168 · see citing works

Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis

Srinivasan, M., & Lahiri, D. K. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.989834 · Cited by 164 · see citing works

Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth

Tu, S. P., Jin, H., Shi, J. D., Zhu, L. M., Suo, Y., Lü, G., Liu, A., Wang, T. C., & Yang, C. S. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0247 · Cited by 167 · see citing works

Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes

Barnes, P. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.052 · Cited by 161 · see citing works

Vascular Endothelial Growth Factor Stimulates Endothelial Colony Forming Cells Proliferation and Tubulogenesis by Inducing Oscillations in Intracellular Ca2+ Concentration

Dragoni, S., Laforenza, U., Bonetti, E., Lodola, F., Bottino, C., Berra‐Romani, R., Bongio, G. C., Cinelli, M. P., Guerra, G., Pedrazzoli, P., et al. (2011) · Stem Cells · doi:10.1002/stem.734 · Cited by 158 · see citing works

Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis

Custodero, C., Mankowski, R. T., Lee, S. A., Chen, Z., Wu, S. S., Manini, T. M., Hincapie-Echeverri, J., Sabbà, C., Beavers, D. P., Cauley, J. A., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.004 · Cited by 158 · see citing works

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

Shah, F., Logsdon, D. P., Messmann, R. A., Fehrenbacher, J. C., Fishel, M. L., & Kelley, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0023-0 · Cited by 153 · see citing works

Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space

Schwaid, A. G., & Spencer, K. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01307 · Cited by 152 · see citing works

NF-κB: master regulator of cellular responses in health and disease

Hoffmann, A., Cheng, G., & Baltimore, D. (2025) · Immunity & Inflammation · doi:10.1007/s44466-025-00014-0 · Cited by 169 · see citing works

Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis

Huang, B., Liu, J., Meng, T., Li, Y., He, D., Ran, X., Chen, G., Guo, W., Kan, X., Fu, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02527 · Cited by 147 · see citing works

The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors

Sarısözen, C., Abouzeid, A. H., & Torchilin, V. P. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.001 · Cited by 145 · see citing works

Role of nuclear factor- κ B-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents

Gupta, S. C., Kim, J. H., Kannappan, R., Reuter, S., Dougherty, P. M., & Aggarwal, B. B. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011028 · Cited by 144 · see citing works

Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer

Campbell, L. M., Maxwell, P. J., & Waugh, D. J. J. (2013) · Pharmaceuticals · doi:10.3390/ph6080929 · Cited by 142 · see citing works

CDK8/19 Mediator kinases potentiate induction of transcription by NFκB

Chen, M., Liang, J., Ji, H., Yang, Z., Altilia, S., Hu, B., Schronce, A., McDermott, M. S. J., Schools, G. P., Lim, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710467114 · Cited by 141 · see citing works

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors

Prescott, J. A., & Cook, S. J. (2018) · Cells · doi:10.3390/cells7090115 · Cited by 139 · see citing works

Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways

Haydar, D., Cory, T. J., Birket, S. E., Murphy, B. S., Pennypacker, K. R., Sinai, A. P., & Feola, D. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801228 · Cited by 136 · see citing works

Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases

Yeo, I. J., Lee, C., Han, S., Yun, J., & Hong, J. T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107394 · Cited by 135 · see citing works

Tocotrienols fight cancer by targeting multiple cell signaling pathways

Kannappan, R., Gupta, S. C., Kim, J. H., & Aggarwal, B. B. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0220-3 · Cited by 132 · see citing works

Inhibitory kappa B kinases as targets for pharmacological regulation

Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 132 · see citing works

In vitro anti-inflammatory activity of phenolic rich extracts from white and red common beans

Garcia-Lafuente, A. M., Moro, C., MANCHÓN, N., Gonzalo‐Ruiz, A., Villares, A., Guillamón, E., Rostagno, M. A., & Mateo‐Vivaracho, L. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.04.004 · Cited by 131 · see citing works

Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment

Zhang, J., Späth, S. S., Marjani, S. L., Zhang, W., & Pan, X. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby007 · Cited by 128 · see citing works

Health Promoting Effects of Brassica-Derived Phytochemicals: From Chemopreventive and Anti-Inflammatory Activities to Epigenetic Regulation

Wagner, A. E., Terschluesen, A. M., & Rimbach, G. H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/964539 · Cited by 127 · see citing works

Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease

Μaione, F., Piccolo, M., Vita, S. D., Chini, M. G., Cristiano, C., Caro, C. D., Lippiello, P., Miniaci, M. C., Santamaria, R., Irace, C., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.018 · Cited by 126 · see citing works

Triterpenoids from Ganoderma lucidum and Their Potential Anti-inflammatory Effects

Wu, Y., Han, F., Luan, S., Ai, R., Zhang, P., Li, H., & Chen, L. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01195 · Cited by 124 · see citing works

Advances in anti-cancer effects and underlying mechanisms of marine algae polysaccharides

Yao, W., Qiu, H., Cheong, K., & Zhong, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.055 · Cited by 123 · see citing works

Transcription Factor Inhibition: Lessons Learned and Emerging Targets

Chen, A. W., & Koehler, A. N. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.004 · Cited by 118 · see citing works

<scp>NF</scp>‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases

Kanigur Sultuybek, G., Soydas, T., & Yenmis, G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13073 · Cited by 119 · see citing works

Aging: Molecular Pathways and Implications on the Cardiovascular System

de Almeida, A. J. P. O., Ribeiro, T. P., & de Medeiros, I. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7941563 · Cited by 117 · see citing works

Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia

Qin, S., Yang, C., Huang, W., Du, S., Mai, H., Xiao, J., & Lü, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.014 · Cited by 118 · see citing works

Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment

Zeligs, K., Neuman, M. K., & Annunziata, C. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1374 · Cited by 116 · see citing works

Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-κB pathways

Wang, W. J., Liu, P., Hao, C., Wu, L., Wan, W., & Mao, X. (2017) · Scientific Reports · doi:10.1038/srep44252 · Cited by 115 · see citing works

Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

Harrison, I. F., Smith, A. D., & Dexter, D. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.037 · Cited by 115 · see citing works

Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer

Yang, G., Shen, W., Zhang, Y., Liu, M., Zhang, L., Liu, Q., Lu, H. H., & Bo, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16386 · Cited by 114 · see citing works

A multi-targeted approach to suppress tumor-promoting inflammation

Samadi, A. K., Bilsland, A. E., Georgakilas, A. G., Amedei, A., Amin, A., Bishayee, A., Azmi, A. S., Lokeshwar, B. L., Grue, B., Panis, C., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.006 · Cited by 113 · see citing works

Models for the study of skin wound healing. The role of Nrf2 and NF-κB

Ambrožová, N., Jitka Ulrichová, A., & Galandáková, A. (2017) · Biomedical Papers · doi:10.5507/bp.2016.063 · Cited by 112 · see citing works

The natural (poly)phenols as modulators of microglia polarization via TLR4/NF-κB pathway exert anti-inflammatory activity in ischemic stroke

Li, R., Zhou, Y., Zhang, S., Li, J., Zheng, Y., & Fan, X. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174660 · Cited by 112 · see citing works

Resveratrol protects quail hepatocytes against heat stress: modulation of the Nrf2 transcription factor and heat shock proteins

Şahin, K., Orhan, C., Akdemir, F., Tuzcu, M., Iben, C., & Şahin, N. (2011) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2010.01123.x · Cited by 111 · see citing works

Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models

Sarısözen, C., Dhokai, S., Tsikudo, E. G., Luther, E., Rachman, I. M., & Torchilin, V. P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.013 · Cited by 108 · see citing works

NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications

Leibowitz, S., & Yan, J. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00084 · Cited by 98 · see citing works

Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells

Silva, V. R., Santos, L. D. S., Dias, R. B., Quadros, C. A., & Bezerra, D. P. (2021) · 癌症：英文版 · doi:10.1002/cac2.12235 · Cited by 106 · see citing works

Antibacterial and anti-inflammatory activities of cardamom (Elettaria cardamomum) extracts: Potential therapeutic benefits for periodontal infections

Souissi, M., Azelmat, J., Chaieb, K., & Grenier, D. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.102089 · Cited by 105 · see citing works

Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment

Gupta, S. C., Prasad, S., Rajalekshmi, D. S., Nair, M. S., Mo, Y.-Y., & Aggarwal, B. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0080 · Cited by 104 · see citing works

Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury

Huang, Z., Shi, Y., Zhai, Y., Du, C.-C., Zhai, J., Yu, R.-J., Kou, L., Xiao, J., Zhao, Y., & Yao, Q. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.033 · Cited by 104 · see citing works

Sirtuin-1 (SIRT1) Is Required for Promoting Chondrogenic Differentiation of Mesenchymal Stem Cells

Buhrmann, C., Busch, F., Shayan, P., & Shakibaei, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568790 · Cited by 103 · see citing works

Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury

Kim, S., Lee, S. A., Yoon, H., Kim, M. Y., Yoo, J.-K., Ahn, S.-H., Park, C. H., Park, J., Nam, B. Y., Park, J. T., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.039 · Cited by 100 · see citing works

Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II–Induced Atrial Fibrillation in Mice

Li, J., Wang, S., Bai, J., Yang, X., Zhang, Y., Che, Y., Li, H., & Yang, Y. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10390 · Cited by 100 · see citing works

Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?

Tafani, M., Pucci, B., Russo, A., Schito, L., Pellegrini, L., Perrone, G. A., Villanova, L., Salvatori, L., Ravenna, L., Petrangeli, E., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00013 · Cited by 99 · see citing works

Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization

Qian, Z., Rhodes, C. A., McCroskey, L. C., Wen, J., Appiah‐Kubi, G., Wang, J., D, D. C. G., & Pei, D. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201610888 · Cited by 99 · see citing works

Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes

Busch, F., Mobasheri, A., Shayan, P., Lueders, C., Stahlmann, R., & Shakibaei, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377028 · Cited by 98 · see citing works

NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?

Roberti, A., Chaffey, L., & Greaves, D. R. (2022) · Biology · doi:10.3390/biology11030372 · Cited by 103 · see citing works

Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF

Jiang, M., Zhou, M., Han, Y., Xing, L., Zhao, H., Dong, L., Bai, G., & Luo, G. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.03.032 · Cited by 97 · see citing works

Neuroimmune Pathways in Alcohol Consumption: Evidence from Behavioral and Genetic Studies in Rodents and Humans

Robinson, G., Most, D., Ferguson, L. B., Mayfield, J., Harris, R. A., & Blednov, Y. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00002-6 · Cited by 96 · see citing works

Peroxisome Proliferator‐Activated Receptorsαandγare Linked with Alcohol Consumption in Mice and Withdrawal and Dependence in Humans

Blednov, Y. A., Benavidez, J. M., Black, M., Ferguson, L. B., Schoenhard, G. L., Goate, A., Edenberg, H. J., Wetherill, L. F., HESSELBROCK, V. M., Foroud, T., et al. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12610 · Cited by 96 · see citing works

Chemokine Receptor Signaling and the Hallmarks of Cancer

Lacalle, R. A., Blanco, R., Carmona‐Rodríguez, L., Martín‐Leal, A., Mira, E., & Mañes, S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.011 · Cited by 96 · see citing works

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer

Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,581 · see citing works

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,236 · see citing works

Inhibitors of NF-κB signaling: 785 and counting

Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 571 · see citing works

Design of small molecules targeting transcriptional activation by NF-κB: overview of recent advances

Straus, D. S. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903143739 · Cited by 13 · see citing works

Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

Aggarwal, B. B., Sethi, G., Nair, S. A., & Ichikawa, H. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269235 · Cited by 61 · see citing works